jili golden empire
jili golden empire
ATLANTA , Dec. 23, 2024 /PRNewswire/ -- KORE Group Holdings, Inc. (NYSE: KORE) ("KORE" or the "Company"), the global pure-play Internet of Things ("IoT") hyperscaler and provider of IoT Connectivity, Solutions, and Analytics, today announced it has received notification (the "Acceptance Letter") from the New York Stock Exchange (the "NYSE") that the NYSE has accepted the Company's previously-submitted plan (the "Plan") to regain compliance with the NYSE's continued listing standards set forth in Section 802.01B of the NYSE Listed Company Manual relating to minimum market capitalization and stockholders' equity. In the Acceptance Letter, the NYSE granted the Company an 18-month period from September 12, 2024 (the "Plan Period") to regain compliance with the continued listing standards. As part of the Plan, the Company is required to provide the NYSE quarterly updates regarding its progress towards the goals and initiatives in the Plan. In the Plan, Kore included details regarding previously reported operational restructuring activities, as well as an outlook on the Company's business. The Company expects its common stock will continue to be listed on the NYSE during the Plan Period, subject to the Company adherence to the Plan and compliance with other applicable NYSE continued listing standards. The Company's receipt of such notification from the NYSE does not affect the Company's business, operations or reporting requirements with the U.S. Securities and Exchange Commission. Cautionary Note on Forward-Looking Statements This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "guidance," "project," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "potential," "seem," "seek," "future," "outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding expected progress with the Company's compliance plan submitted to the NYSE, expected compliance with continued listing standards of the NYSE and expected continued listing of the Company's common stock on the NYSE. These statements are based on various assumptions and on the current expectations of KORE's management. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor or other person as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of KORE. These forward-looking statements are subject to a number of risks and uncertainties, including general economic, financial, legal, political and business conditions and changes in domestic and foreign markets; the potential effects of COVID-19; risks related to the rollout of KORE's business and the timing of expected business milestones; risks relating to the integration of KORE's acquired companies, including the acquisition of Twilio's IoT business, changes in the assumptions underlying KORE's expectations regarding its future business; our ability to negotiate and sign a definitive contract with a customer in our sales funnel; our ability to realize some or all of estimates relating to customer contracts as revenue, including any contractual options available to customers or contractual periods that are subject to termination for convenience provisions; the effects of competition on KORE's future business; and the outcome of judicial proceedings to which KORE is, or may become a party. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that KORE presently does not know or that KORE currently believes are immaterial that could also cause actual results to differ materially from those contained in the forward-looking statements. In addition, forward-looking statements reflect KORE's expectations, plans or forecasts of future events and views as of the date of this press release. KORE anticipates that subsequent events and developments will cause these assessments to change. However, while KORE may elect to update these forward-looking statements at some point in the future, KORE specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing KORE's assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements. KORE Investor Contact: Vik Vijayvergiya Vice President, IR, Corporate Development and Strategy vvijayvergiya@korewireless.com (770) 280-0324 View original content to download multimedia: https://www.prnewswire.com/news-releases/kore-announces-nyse-acceptance-of-plan-to-regain-listing-compliance-302338621.html SOURCE KORE Group Holdings, Inc.Several times following New England’s 24-21 loss to the Buffalo Bills, Patriots coach Jerod Mayo said he wanted to review the game film before making a final assessment of his team’s performance. He did, and on Monday he said the overarching feeling he was left with was one of pride. Going toe-to-toe with one of the best teams in the NFL is commendable. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get any of our free email newsletters — news headlines, obituaries, sports, and more.
The PGA Tour announced its schedule of seven post-season tournaments for the fall of 2025 on Tuesday with no Las Vegas event on the calendar for the first time since 1983. The lineup is one fewer than this year and tees off with the Procore Championship in Napa, California, on September 11-14, two weeks after the 2025 Tour Championship. Absent from the schedule is the Shriners Children's Open in Las Vegas. After the Ryder Cup next September at Bethpage Black, the PGA Tour events resume with the Sanderson Farms Championship on October 2-5. The PGA Tour's Japan stop, the Baycurrent Classic, will be October 9-12 at Yokohama Country Club followed by the Black Desert Championship on October 23-26 in Utah. The World Wide Technology Championship at Los Cabos, Mexico, will be November 6-9 followed the next week by the Bermuda Championship and the RSM Classic on November 20-23 at Sea Island, Georgia. More from this section "With events in four US states, Japan, Mexico and Bermuda, the conclusion to the 2025 golf calendar promises to be exciting for our fans worldwide," said Tyler Dennis, PGA Tour chief competitions officer. Under tighter qualifying rules for the 2026 PGA Tour approved by the Player Advisory Council last month, only the top 70 players in the FedEx Cup standings will secure exempt status with the 50 who reach next year's BMW Championship being exempt into signature events for 2026. Those ranked 51st and beyond will take FedEx Cup points into the fall to try and accumulate eligibility points for the 2026 campaign. Three PGA Tour Challenge season events will be played next December -- the Hero World Challenge in the Bahamas hosted by Tiger Woods, the LPGA-PGA mixed-team Grant Thornton Invitational and the PNC Championship parent-child event. Tour commissioner Jay Monahan also announced Tuesday that the PGA is searching for a new chief executive officer whose job would be to grow the business side of the operation in light of the $1.5 billion investment in PGA Tour Enterprises by Strategic Sports Group, a set of team sports owners. js/bbChelsea: Enzo Maresca confident in Premier League referees after David Coote scandalWhen Inter Miami were dumped out of Major League Soccer's playoffs in the first round, their former Spain international full-back Jordi Alba questioned the fairness of the post-season format. Miami had topped the Eastern Conference and the overall regular season standings with a record points tally a performance which earned them the 'Supporters' Shield'. But there would be no title battle against the best in the West for Lionel Messi and Company after they contrived to lose two matches in their best-of-three series against an Atlanta United team which finished ninth in the East and 20th in the overall standings. "I think this format is a bit unfair. It has been done for many years but I think it should be the champion of one conference against the champion of the other, to make it as fair as possible," Alba said. Alba's comments prompted much debate among MLS fans and plenty of accusations of sour grapes but they did serve to highlight that this year's playoffs, if not MLS's playoffs in general, would certainly not be a battle of the best versus best. Defending champions Columbus Crew, who finished second in the Supporters' Shield race, were also eliminated in the first round, adding to the sense that the knockout phase of the season is very much a competition of its own. So on Saturday, after the international break disrupted the flow of the post-season, the Conference semi-finals, will see a "Hudson River Derby" between two New York teams who couldn't finish in the top 10 in the regular season. New York City, Manchester City's sister club, have home-field advantage after finishing in 13th spot while the New York Red Bulls travel from New Jersey, having ended up in 16th place. The 'home field' isn't actually NYCFC's usual home of Yankee Stadium, which is being used for a college football game, but Citi Field, home of New York's other baseball club, the Mets. Later on Saturday, in the Western Conference, 2022 MLS Cup winners and last year's beaten finalists, Los Angeles FC, are at home to the Seattle Sounders. That fixture feels much more like the kind of playoff game that was expected -- LAFC finished top of the West while Seattle were fourth. LAFC faces the Sounders for the fourth time in an elimination match over the last 13 months, having defeated Seattle in the 2023 Western Conference semifinals, the 2024 Leagues Cup quarterfinal and the 2024 US Open Cup semifinal. Each of those matches was hosted by Seattle. LAFC, with former France stars in goalkeeper Hugo Lloris and striker Olivier Giroud, enter the encounter unbeaten in their last 10 meetings with the Sounders, with their last loss to Seattle coming in a 2-0 defeat in 2021. On Sunday, surprise package Atlanta, with their 40-year-old goalkeeper Brad Guzan having impressed so many with his heroics against Miami, will return to Florida to take on Orlando City, who finished fourth in the East. Atlanta won at Orlando on the last day of the regular campaign, a victory that allowed them to sneak into the wildcard round but which also completed a home and away double for the Georgia side. "Obviously, in Major League Soccer, anything can happen," said Orlando coach Oscar Pareja. "Our responsibility is to play one game at a time. This one, we're going to be ready for sure," he added. The weekend rounds off with Los Angeles Galaxy hosting Minnesota United who, under former Manchester United assistant coach Eric Ramsay, came through a best-of-three series against higher-ranked Real Salt Lake. The Galaxy start as favourites but, as this season has shown in abundance, that counts for little. "We know they are a top team at this level with top individual players who are very difficult to beat at home but...I feel that if we are a good version of what we have been over the last 10-12 games... I certainly won't be painting it as a one sided game," said Ramsay. sev/js
THOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday , Dec. 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, Jay Bradner , executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney , executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) SOURCE AmgenIs Lip Blushing Worth It? Here's Everything to Know Before Tattooing Your Lips
( MENAFN - Brazil-Arab News Agency (ANBA)) São Paulo – The Palestinian Minister of Religious and Islamic Affairs, Mahmoud Al-Habbash, told ANBA on Monday (2) that Brazil plays an influential role on the global stage and that this influence can be leveraged to garner more support for the Arab country's causes. Al-Habbash, along with the Palestinian ambassador and dean of the Council of Arab Ambassadors in Brazil, Ibrahim Alzeben; Al-Habbash's advisor, Hamza Daana; Judge Maher Khudeir; and the embassy's minister-counselor, Ahmed Al Assad, visited the Arab-Brazilian Chamber of Commerce (ABCC ) on Monday morning. They were welcomed by the institution's president, Osmar Chohfi, and secretary-general and vice president of international relations, Mohamad Mourad. Al-Habbash reiterated that Palestine seeks to join the BRICS group of developing countries, which includes Brazil, Russia, India, China, South Africa, Egypt, the United Arab Emirates, Iran, and Ethiopia. “Palestine has good relations with all the countries in the group. China, South Africa, and Russia are historically friendly nations to the Palestinian people. We have requested membership in the group and submitted a request to join the NDB (New Development Bank, the BRICS bank),” he said, noting that while BRICS is an economic cooperation bloc, economics and politics cannot be separated. The minister also said that Palestine seeks a“just peace” in the Middle East and advocated for the existence of two states: Israel and Palestine. He added that the president of Palestine, Mahmoud Abbas, is expected to visit Brazil in the second half of 2025, noting that Abbas and Brazilian President Luiz Inácio Lula da Silva share a good personal relationship. During his visit to Brazil to attend the 37th Annual Conference of Latin American and Caribbean Muslims, held from November 29 to last Sunday (1), Al-Habbash was scheduled to meet with São Paulo authorities on Monday as well. In the afternoon, he was set to meet with the State Secretary of Government and Institutional Relations of São Paulo Gilberto Kassab, along with State Representative Maurici Morais, who chairs the International Relations Committee at the São Paulo State Legislative Assembly. Read more: Brazil joins humanitarian conference on Gaza Translated by Guilherme Miranda The post Palestinian minister: Country seeks to join BRICS appeared first on ANBA News Agency . MENAFN02122024000213011057ID1108948999 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
NASA announced the latest delay in Butch Wilmore and Suni Williams' homecoming Tuesday. The two test pilots planned to be away just a week or so when they blasted off June 5 on Boeing's first astronaut flight to the International Space Station. Their mission grew from eight days to eight months after NASA decided to send the company's problem-plagued Starliner capsule back empty in September. Listen now and subscribe: Apple Podcasts | Spotify | RSS Feed | SoundStack | All Of Our Podcasts Now the pair won't return until the end of March or even April because of a delay in launching their replacements, according to NASA. A fresh crew needs to launch before Wilmore and Williams can return and the next mission was bumped more than a month, according to the space agency. NASA's next crew of four was supposed to launch in February, followed by Wilmore and Williams' return home by the end of that month alongside two other astronauts. But SpaceX needs more time to prepare the new capsule for liftoff. That launch is now scheduled for no earlier than late March. NASA said it considered using a different SpaceX capsule to fly up the replacement crew in order to keep the flights on schedule. However, it decided the best option was to wait for the new capsule to transport the next crew. NASA prefers to have overlapping crews at the space station for a smoother transition, according to officials. Most space station missions last six months, with a few reaching a full year.Brisbane news live: PM condemns ‘another antisemitic attack’Apollo Commercial Real Estate Finance, Inc. Declares Quarterly Common Stock Dividend
Monport Laser Unwraps the "Christmas Laser Bonanza" - Spark Your Creativity with Unbeatable Festive Offers
Aries - (21st March to 19th April) Daily Horoscope Prediction says, Harness Your Inner Strength Your dynamic energy boosts personal connections and enhances career prospects. Stay open-minded and focus on nurturing relationships for long-term happiness. Today, Aries, your vibrant energy is contagious, positively impacting both your personal and professional life. It's a great time to connect with others and share ideas. While opportunities are on the horizon, maintaining balance is key. Stay open to feedback and make time for those you cherish. This approach will not only elevate your mood but also foster long-lasting relationships and success in your endeavors. Aries Love Horoscope Today: In love, your enthusiasm is likely to make a significant impact. Single Aries may find new romantic interests through casual social interactions, so be open to meeting new people. For those in relationships, it's a day to focus on your partner's needs. Showing appreciation through small gestures can enhance your bond and bring you closer. Remember, communication is crucial. Share your feelings openly to strengthen mutual understanding and emotional connection. Aries Career Horoscope Today: Professionally, you're in the spotlight today, Aries. Your ideas and leadership are likely to gain recognition, setting the stage for potential advancement. Use this opportunity to network and share your vision with colleagues. However, be mindful of overextending yourself. Prioritize tasks and manage your time effectively to ensure productivity without burnout. Stay receptive to constructive feedback, which can help refine your approach and contribute to your ongoing success. Aries Money Horoscope Today: Financially, today presents a good opportunity to evaluate your spending habits. You might discover areas where you can save or invest more wisely. Although it's tempting to make impulsive purchases, it's advisable to plan your expenses carefully. Consider seeking professional financial advice if you're thinking of long-term investments. Staying informed and making thoughtful decisions will lead to greater financial security and peace of mind in the future. Aries Health Horoscope Today: Your health is generally stable today, Aries, but it's essential to maintain your energy levels through balanced nutrition and regular exercise. Consider incorporating stress-relief practices, like meditation or yoga, into your routine to enhance mental well-being. Pay attention to your body's signals; rest when needed to avoid fatigue. By taking care of your physical and emotional health, you can sustain your vibrant energy and maintain a positive outlook throughout the day. Aries Sign Attributes Strength: Optimistic, Energetic, Sincere, Multitalented, Venturesome, generous, cheerful, curious Weakness: Reckless, Argumentative, Loud-mouthed, Impatient Symbol: Ram Element: Fire Body Part: Head Sign Ruler: Mars Lucky Day: Tuesday Lucky Color: Red Lucky Number: 5 Lucky Stone: Ruby Aries Compatibility Chart Natural affinity: Gemini, Leo, Sagittarius, Aquarius Good compatibility: Aries, Libra Fair compatibility: Taurus, Virgo, Scorpio, Pisces Less compatibility: Cancer, Capricorn By: Dr. J. N. Pandey Vedic Astrology & Vastu Expert Website: www.astrologerjnpandey.com E-mail: djnpandey@gmail.com Phone: 91-9811107060 (WhatsApp Only)President-elect Donald Trump mocked Canadian Prime Minister Justin Trudeau - again - by calling him "governor" after suggesting that his country become the 51st state . “It was a pleasure to have dinner the other night with Governor Justin Trudeau of the Great State of Canada,” Trump wrote on Truth Social Monday night. “I look forward to seeing the Governor again soon so that we may continue our in-depth talks on Tariffs and Trade, the results of which will be truly spectacular for all!” Trump has been threatening to enact 25% tariffs on all imports from Canada and Mexico as well as increase tariffs already in place on China. What else did Trump say about Canada and tariffs? Trump recently joked that Canada should become the 51st state, even suggesting it directly to Trudeau during their dinner at Mar-a-Lago, Fox News reported. Trudeau later told reporters that his conversation with Trump had been "excellent" but didn't comment beyond that. But on Sunday, the president-elect told NBC’s Meet the Press , "We’re subsidizing Canada to the tune of over $100 billion a year. We’re subsidizing Mexico for almost $300 billion. We shouldn’t be — why are we subsidizing these countries? If we’re going to subsidize them, let them become a state." How has Trudeau responded to threats of tariffs? Trudeau pushed back against Trump's tariff threats at a Halifax Chamber of Commerce event Monday, saying Americans “are beginning to wake up to the real reality that tariffs on everything from Canada would make life a lot more expensive,” the Associated Press reported. “It would also, however, mean real hardship for Americans as well," said the Canadian leader. "They [Americans] rely on us for steel and aluminum. They rely on us for a range of agriculture imports. All of those things would get more expensive,” he said.NASA's 2 stuck astronauts face more time in space with return delayed until at least late March
Some Atlantic City casino workers call on union boss to resign for opposing a smoking ban
- Previous:
- Next: golden empire jili
